Literature DB >> 19734423

Single nucleotide polymorphism genomic arrays analysis of t(8;21) acute myeloid leukemia cells.

Tadayuki Akagi1, Lee-Yung Shih, Seishi Ogawa, Joachim Gerss, Stephen R Moore, Rhona Schreck, Norihiko Kawamata, Der-Cherng Liang, Masashi Sanada, Yasuhito Nannya, Stefan Deneberg, Vasilios Zachariadis, Ann Nordgren, Jee Hoon Song, Martin Dugas, Sören Lehmann, H Phillip Koeffler.   

Abstract

Translocation of chromosomes 8 and 21, t(8;21), resulting in the AML1-ETO fusion gene, is associated with acute myeloid leukemia. We searched for additional genomic abnormalities in this acute myeloid leukemia subtype by performing single nucleotide polymorphism genomic arrays (SNP-chip) analysis on 48 newly diagnosed cases. Thirty-two patients (67%) had a normal genome by SNP-chip analysis (Group A), and 16 patients (33%) had one or more genomic abnormalities including copy number changes or copy number neutral loss of heterozygosity (Group B). Two samples had copy number neutral loss of heterozygosity on chromosome 6p including the PIM1 gene; and one of these cases had E135K mutation of Pim1. Interestingly, 38% of Group B and only 13% of Group A samples had a KIT-D816 mutation, suggesting that genomic alterations are often associated with a KIT-D816 mutation. Importantly, prognostic analysis revealed that overall survival and event-free survival of individuals in Group B were significantly worse than those in Group A.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19734423      PMCID: PMC2738725          DOI: 10.3324/haematol.2009.005744

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  24 in total

1.  Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas.

Authors:  L Pasqualucci; P Neumeister; T Goossens; G Nanjangud; R S Chaganti; R Küppers; R Dalla-Favera
Journal:  Nature       Date:  2001-07-19       Impact factor: 49.962

2.  In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia.

Authors:  Joseph L Wiemels; Zhijian Xiao; Patricia A Buffler; Ana T Maia; Xiaomei Ma; Brian M Dicks; Martyn T Smith; Luoping Zhang; James Feusner; John Wiencke; Kathy Pritchard-Jones; Helena Kempski; Mel Greaves
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

3.  AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations.

Authors:  Y Yuan; L Zhou; T Miyamoto; H Iwasaki; N Harakawa; C J Hetherington; S A Burel; E Lagasse; I L Weissman; K Akashi; D E Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

4.  Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model.

Authors:  K L Rhoades; C J Hetherington; N Harakawa; D A Yergeau; L Zhou; L Q Liu; M T Little; D G Tenen; D E Zhang
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

5.  Trisomy 4 leading to duplication of a mutated KIT allele in acute myeloid leukemia with mast cell involvement.

Authors:  A Beghini; C B Ripamonti; P Castorina; L Pezzetti; L Doneda; R Cairoli; E Morra; L Larizza
Journal:  Cancer Genet Cytogenet       Date:  2000-05

6.  Chromosome translocations and covert leukemic clones are generated during normal fetal development.

Authors:  Hiroshi Mori; Susan M Colman; Zhijian Xiao; Anthony M Ford; Lyn E Healy; Craig Donaldson; Jill M Hows; Cristina Navarrete; Mel Greaves
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

7.  Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation.

Authors:  Manuel Montesinos-Rongen; Dirk Van Roost; Carlo Schaller; Otmar D Wiestler; Martina Deckert
Journal:  Blood       Date:  2003-10-30       Impact factor: 22.113

8.  Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias.

Authors:  Rory S Care; Peter J M Valk; Anne C Goodeve; Faisel M Abu-Duhier; Wendy M C Geertsma-Kleinekoort; Giu A Wilson; Mamdooh A Gari; Ian R Peake; Bob Löwenberg; John T Reilly
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

9.  Hidden abnormalities and novel classification of t(15;17) acute promyelocytic leukemia (APL) based on genomic alterations.

Authors:  Tadayuki Akagi; Lee-Yung Shih; Motohiro Kato; Norihiko Kawamata; Go Yamamoto; Masashi Sanada; Ryoko Okamoto; Carl W Miller; Der-Cherng Liang; Seishi Ogawa; H Phillip Koeffler
Journal:  Blood       Date:  2008-12-23       Impact factor: 22.113

10.  Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia.

Authors:  Masakazu Higuchi; Darin O'Brien; Parasakthy Kumaravelu; Noel Lenny; Eng-Juh Yeoh; James R Downing
Journal:  Cancer Cell       Date:  2002-02       Impact factor: 31.743

View more
  7 in total

Review 1.  PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers.

Authors:  Laurent Brault; Christelle Gasser; Franz Bracher; Kilian Huber; Stefan Knapp; Jürg Schwaller
Journal:  Haematologica       Date:  2010-02-09       Impact factor: 9.941

Review 2.  Genomic analysis of acute myeloid leukemia: potential for new prognostic indicators.

Authors:  Elizabeth A Eklund
Journal:  Curr Opin Hematol       Date:  2010-03       Impact factor: 3.284

3.  Chromosomal minimal critical regions in therapy-related leukemia appear different from those of de novo leukemia by high-resolution aCGH.

Authors:  Nathalie Itzhar; Philippe Dessen; Saloua Toujani; Nathalie Auger; Claude Preudhomme; Catherine Richon; Vladimir Lazar; Véronique Saada; Anelyse Bennaceur; Jean Henri Bourhis; Stéphane de Botton; Alain Bernheim
Journal:  PLoS One       Date:  2011-02-14       Impact factor: 3.240

4.  Clinical significance of previously cryptic copy number alterations and loss of heterozygosity in pediatric acute myeloid leukemia and myelodysplastic syndrome determined using combined array comparative genomic hybridization plus single-nucleotide polymorphism microarray analyses.

Authors:  Kyung-Nam Koh; Jin Ok Lee; Eul Ju Seo; Seong Wook Lee; Jin Kyung Suh; Ho Joon Im; Jong Jin Seo
Journal:  J Korean Med Sci       Date:  2014-07-11       Impact factor: 2.153

5.  PIM1 polymorphism and PIM1 expression as predisposing factors of esophageal squamous cell carcinoma in the Asian population.

Authors:  Yuan-Bo Wu; Di Lu; Zhi-Feng He; Chan-Guan Jin
Journal:  Onco Targets Ther       Date:  2016-05-17       Impact factor: 4.147

6.  Effect of single amino acid substitution observed in cancer on Pim-1 kinase thermodynamic stability and structure.

Authors:  Clorinda Lori; Antonella Lantella; Alessandra Pasquo; Leila T Alexander; Stefan Knapp; Roberta Chiaraluce; Valerio Consalvi
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

Review 7.  Use of single nucleotide polymorphism array technology to improve the identification of chromosomal lesions in leukemia.

Authors:  Ilaria Iacobucci; Annalisa Lonetti; Cristina Papayannidis; Giovanni Martinelli
Journal:  Curr Cancer Drug Targets       Date:  2013-09       Impact factor: 3.428

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.